When medicine is written in code, how do you market the cure? A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms? In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape. Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: ¿ What digital therapeutics are - and how they differ from wellness apps. ¿ Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks. ¿ How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs. ¿ Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health. ¿ The role of AI, wearables, and telemedicine in scaling digital care. ¿ Strategic frameworks for commercialization, adoption, and measuring success. Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded. Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 52882357-n
Quantité disponible : Plus de 20 disponibles
Vendeur : BargainBookStores, Grand Rapids, MI, Etats-Unis
Paperback or Softback. Etat : New. Code to Cure: Digital Therapeutics and the Future of Pharma. Book. N° de réf. du vendeur BBS-9789347311147
Quantité disponible : 5 disponible(s)
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
HRD. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9789347311147
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 52882357
Quantité disponible : Plus de 20 disponibles
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Hardcover. Etat : new. Hardcover. When medicine is written in code, how do you market the cure?A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms?In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape.Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: - What digital therapeutics are - and how they differ from wellness apps.- Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks.- How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs.- Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health.- The role of AI, wearables, and telemedicine in scaling digital care.- Strategic frameworks for commercialization, adoption, and measuring success.Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded.Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9789347311147
Quantité disponible : 1 disponible(s)
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
HRD. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9789347311147
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 52882357-n
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 52882357
Quantité disponible : Plus de 20 disponibles
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Hardcover. Etat : new. Hardcover. When medicine is written in code, how do you market the cure?A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms?In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape.Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: - What digital therapeutics are - and how they differ from wellness apps.- Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks.- How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs.- Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health.- The role of AI, wearables, and telemedicine in scaling digital care.- Strategic frameworks for commercialization, adoption, and measuring success.Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded.Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9789347311147
Quantité disponible : 1 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Hardcover. Etat : new. Hardcover. When medicine is written in code, how do you market the cure?A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms?In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape.Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: - What digital therapeutics are - and how they differ from wellness apps.- Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks.- How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs.- Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health.- The role of AI, wearables, and telemedicine in scaling digital care.- Strategic frameworks for commercialization, adoption, and measuring success.Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded.Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9789347311147
Quantité disponible : 1 disponible(s)